EFT Holdings, Inc. - FORM 10-Q - EX-32 - EXHIBIT 32 - November 9, 2010

Attached files

file filename
10-Q - SEPT 2010 10-Q - EFT Holdings, Inc.sept10q11-10.txt
EX-31 - EXHIBIT 31 - EFT Holdings, Inc.sept10qexh3111-10.txt
 

                                  EXHIBIT 32






      In connection with the quarterly report of EFT BioTech Holdings, Inc.,
(the "Company") on Form 10-Q for the quarter ended September 30, 2010 as filed
with the Securities and Exchange Commission (the "Report") Jack Jie Qin, the
Principal Executive and Principal Financial Officer of the Company, certifies
pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully  complies with the  requirements  of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects, the financial condition and results of operation of
          the company.


 November 8, 2010                         /s/ Jack Jie Qin
                                          ------------------------------
                                          Jack Jie Qin, Principal Executive and
                                          Financial Officer

EFT Holdings, Inc. Reports

Also read